News – Page 5 – Buhlmann Diagnostics Corp

BUHLMANN News

Clinical improvement and reduction in serum calprotectin levels after an intensive exercise programme for patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis

BÜHLMANN sCAL ELISA: Levitova A et al.: Clinical Improvement and Reduction in serum calprotectin levels after an intensive exercise programme for patients with AS and non-radiographic spondyloarthritis; Arthritis Research and Therapy: 2016: 18(1): 275.  PMID: 27887637  doi:  10.1186/s13075-016-1180-1 Read Citation BÜHLMANN sCAL ELISA is for Research Use Only.  Not for use in diagnostic procedures in the US and Canada.
Continue Reading

Serum Calprotectin Discriminates Subclinical Disease Activity from Ultrasound-Defined Remission in Patients with Rheumatoid Arthritis in Clinical Remission

BÜHLMANN sCAL ELISA: Hurnakova J et al.: Serum Calprotectin Discriminates Subclinical Disease Activity from Ultrasound- Defined Remission in Patients with Rheumatoid Arthritis in Clinical Remission; PLoS One; 2016: e0165498.  PMID: 27832086  DOI: 10.1371/journal.pone.0165498 Read Citation BÜHLMANN sCAL ELISA is for Research Use Only.  Not for use in diagnostic procedures in the US and Canada.
Continue Reading

Serum calprotectin (S100A8/9): an independent predictor of ultrasound synovitis in patients with rheumatoid arthritis

BÜHLMANN sCAL ELISA: Hurnakova J et al.: Serum calprotectin (S100A8/9): an independent predictor of ultrasound synovitis in patients with rheumatoid arthritis. Arthritis Research and Therapy. 2015: 17:252.  PMID: 26373925  doi:  10.1186/s13075-015-0764-5 Read Citation BÜHLMANN sCAL ELISA is for Research Use Only.  Not for use in diagnostic procedures in the US and Canada.
Continue Reading

Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis

BÜHLMANN MRP8/14 ELISA: Cypers H et al.: Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis. Annals of the Rheumatic Diseases. 2015.  PMID: 26698844  DOI: 10.1136/annrheumdis-2015-208025 Read Citation BÜHLMANN sCAL ELISA is for Research Use Only.  Not for use in diagnostic procedures in the US and Canada.
Continue Reading

MRP8/14 serum levels as a predictor of response to starting and stopping anti-TNF treatment in juvenile idiopathic arthritis

BÜHLMANN MRP8/14 ELISA: Anink J et al.: MRP8/14 serum levels as a predictor of response to starting and stopping anti-TNF treatment in juvenile idiopathic arthritis. Arthritis Research and Therapy. 2015: 17:200 PMID: 26249667  doi:  10.1186/s13075-015-0723-1 Read Citation BÜHLMANN sCAL ELISA is for Research Use Only.  Not for use in diagnostic procedures in the US and Canada.
Continue Reading

Review of biomarkers in systemic juvenile idiopathic arthritis

BÜHLMANN MRP8/14 ELISA: Rothmund F et al.: Validation of relapse risk biomarkers for routine use in patients with juvenile idiopathic arthritis. Arthritis Care Research (Hoboken). 2014: 66(6):949-55. PMID: 27411444   DOI: 10.1186/s13075-016-1069-z Read Citation BÜHLMANN sCAL ELISA is for Research Use Only.  Not for use in diagnostic procedures in the US and Canada.
Continue Reading

Calprotectin in rheumatoid arthritis : association with disease activity in a cross-sectional and a longitudinal cohort

BÜHLMANN MRP8/14 ELISA: García-Arias M et al.: Calprotectin in rheumatoid arthritis: association with disease activity in a cross-sectional and a longitudinal cohort. Molecular Diagnosis and Therapy. 2013: 17(1):49-56.  PMID: 23329363 DOI: 10.1007/s40291-013-0016-9 Read Citation BÜHLMANN sCAL ELISA is for Research Use Only.  Not for use in diagnostic procedures in the US and Canada.
Continue Reading

Can mHealth Apps replace clinic visits?

US: IBDoc® is not available for sale in the US. Health Canada License: 98903, Device class: 3 Read a recent article in the Journal of mHealth (Volume 3, Issue 3), McCombie and colleagues performed a systematic review of IBD symptom monitoring smartphone apps. Highlight from this Article In this study, 233 separate apps were found on
Continue Reading

Introducing Patient Home Tests for Calprotectin in a Routine District General Hospital

US: IBDoc® is not available for sale in the US. Health Canada License: 98903, Device class: 3 Read a recent interview with Lead Inflammatory Bowel Disease Nurse, Pearl Avery, conducted by BÜHLMANN's UK distributor Alpha Laboratories: Highlight from this Article “In the six months that we have been working with the IBDoc, one patient was
Continue Reading

Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis

BÜHLMANN sCAL ELISA: Andrés Cerezo et al.: Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis. Arthritis Research and Therapy. 2011; 13(4).  PMID: 21791097  DOI: 10.1186/ar3426 . Read Citation BÜHLMANN sCAL ELISA is for Research Use Only.  Not for use in diagnostic procedures in
Continue Reading